Metacycline served as a pharmaceutical intervention intended to alleviate the symptoms of the sickness that afflicted individuals within the Community who were impacted by the Imperial research facility situated on a frozen moon. Its formulation comprised a blend of a genetic coherence sequencer, alongside an antipsychotic agent, and a blood thinner.